ERG promotes T-acute lymphoblastic leukemia and is transcriptionally regulated in leukemic cells by a stem cell enhancer.

The Ets-related gene (ERG) is an Ets-transcription factor required for normal blood stem cell development. ERG expression is down-regulated during early T-lymphopoiesis but maintained in T-acute lymphoblastic leukemia (T-ALL), where it is recognized as an independent risk factor for adverse outcome. However, it is unclear whether ERG is directly involved in the pathogenesis of T-ALL and how its expression is regulated. Here we demonstrate that transgenic expression of ERG causes T-ALL in mice and that its knockdown reduces the proliferation of human MOLT4 T-ALL cells. We further demonstrate that ERG expression in primary human T-ALL cells is mediated by the binding of other T-cell oncogenes SCL/TAL1, LMO2, and LYL1 in concert with ERG, FLI1, and GATA3 to the ERG +85 enhancer. This enhancer is not active in normal T cells but in transgenic mice targets expression to fetal liver c-kit(+) cells, adult bone marrow stem/progenitors and early CD4(-)CD8(-) double-negative thymic progenitors. Taken together, these data illustrate that ERG promotes T-ALL and that failure to extinguish activity of stem cell enhancers associated with regulatory transcription factors such as ERG can contribute to the development of leukemia.

[1]  R. Kominami,et al.  An Essential Developmental Checkpoint for Production of the T Cell Lineage , 2010, Science.

[2]  A. Sharrocks.  The ETS-domain transcription factor family , 2001, Nature Reviews Molecular Cell Biology.

[3]  Pier Paolo Pandolfi,et al.  Aberrant ERG expression cooperates with loss of PTEN to promote cancer progression in the prostate , 2009, Nature Genetics.

[4]  C. Bloomfield,et al.  High expression of the ETS transcription factor ERG predicts adverse outcome in acute T-lymphoblastic leukemia in adults. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[5]  D. Gary Gilliland,et al.  Cancer biology: Summing up cancer stem cells , 2005, Nature.

[6]  Cheng Cheng,et al.  Early T-cell precursor leukaemia: a subtype of very high-risk acute lymphoblastic leukaemia. , 2009, The Lancet. Oncology.

[7]  J. Letterio,et al.  Notch1 mutations are important for leukemic transformation in murine models of precursor-T leukemia/lymphoma. , 2006, Blood.

[8]  P. Sorensen,et al.  A second Ewing's sarcoma translocation, t(21;22), fuses the EWS gene to another ETS–family transcription factor, ERG , 1994, Nature Genetics.

[9]  T. Rabbitts,et al.  The LIM‐only protein Lmo2 is a bridging molecule assembling an erythroid, DNA‐binding complex which includes the TAL1, E47, GATA‐1 and Ldb1/NLI proteins , 1997, The EMBO journal.

[10]  B. Göttgens,et al.  Endoglin expression in the endothelium is regulated by Fli-1, Erg, and Elf-1 acting on the promoter and a -8-kb enhancer. , 2006, Blood.

[11]  B. Göttgens,et al.  A previously unrecognized promoter of LMO2 forms part of a transcriptional regulatory circuit mediating LMO2 expression in a subset of T-acute lymphoblastic leukaemia patients , 2010, Oncogene.

[12]  E. Thiel,et al.  Epigenetic control of differential expression of specific ERG isoforms in acute T-lymphoblastic leukemia. , 2009, Leukemia research.

[13]  E. Rothenberg,et al.  Fine-Scale Staging of T Cell Lineage Commitment in Adult Mouse Thymus , 2010, The Journal of Immunology.

[14]  S. Yamanaka,et al.  Induction of Pluripotent Stem Cells from Mouse Embryonic and Adult Fibroblast Cultures by Defined Factors , 2006, Cell.

[15]  B. Göttgens,et al.  The proto-oncogene ERG in megakaryoblastic leukemias. , 2005, Cancer research.

[16]  A. Bhandoola,et al.  The earliest thymic progenitors for T cells possess myeloid lineage potential , 2008, Nature.

[17]  W. Alexander,et al.  Trisomy of Erg is required for myeloproliferation in a mouse model of Down syndrome. , 2010, Blood.

[18]  Y. Hayashi,et al.  An ets-related gene, ERG, is rearranged in human myeloid leukemia with t(16;21) chromosomal translocation. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[19]  S. Armstrong,et al.  Molecular genetics of acute lymphoblastic leukemia. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[20]  A T Look,et al.  Oncogenic transcription factors in the human acute leukemias. , 1997, Science.

[21]  B. Black,et al.  ETS-dependent regulation of a distal Gata4 cardiac enhancer. , 2012, Developmental biology.

[22]  T. Ikawa,et al.  Adult T-cell progenitors retain myeloid potential , 2008, Nature.

[23]  Mark A. Dawson,et al.  The transcriptional program controlled by the stem cell leukemia gene Scl/Tal1 during early embryonic hematopoietic development. , 2009, Blood.

[24]  W. Pear,et al.  Regulation of lymphoid development, differentiation, and function by the Notch pathway. , 2005, Annual review of immunology.

[25]  F. Alt,et al.  Activating Notch1 mutations in mouse models of T-ALL. , 2005, Blood.

[26]  Andrew P. Weng,et al.  Activating Mutations of NOTCH1 in Human T Cell Acute Lymphoblastic Leukemia , 2004, Science.

[27]  Ellen V. Rothenberg,et al.  Launching the T-cell-lineage developmental programme , 2008, Nature Reviews Immunology.

[28]  N. Sebire,et al.  ERG is a megakaryocytic oncogene. , 2009, Cancer research.

[29]  篠原 隆司,et al.  Induction of pluripotent stem cell cells from germ cells , 2012 .

[30]  Elizabeth A. Kruse,et al.  The transcription factor Erg is essential for definitive hematopoiesis and the function of adult hematopoietic stem cells , 2008, Nature Immunology.

[31]  J. Dick,et al.  Characterization in vitro and engraftment potential in vivo of human progenitor T cells generated from hematopoietic stem cells. , 2009, Blood.

[32]  E. Rothenberg,et al.  Precise developmental regulation of Ets family transcription factors during specification and commitment to the T cell lineage. , 1999, Development.

[33]  W. Alexander,et al.  ERG dependence distinguishes developmental control of hematopoietic stem cell maintenance from hematopoietic specification. , 2011, Genes & development.

[34]  Toshiyuki Yamada,et al.  Molecular biology of the Ets family of transcription factors. , 2003, Gene.

[35]  F. Liu,et al.  Genome-Wide Analysis of the Zebrafish ETS Family Identifies Three Genes Required for Hemangioblast Differentiation or Angiogenesis , 2008, Circulation research.

[36]  C. Antonescu,et al.  ETV1 is a lineage survival factor that cooperates with KIT in gastrointestinal stromal tumours , 2010, Nature.

[37]  W. Ouwehand,et al.  Combinatorial transcriptional control in blood stem/progenitor cells: genome-wide analysis of ten major transcriptional regulators. , 2010, Cell stem cell.

[38]  C. D. de Graaf,et al.  The Lmo2 Oncogene Initiates Leukemia in Mice by Inducing Thymocyte Self-Renewal , 2010, Science.

[39]  J. Crispino,et al.  ETS2 and ERG promote megakaryopoiesis and synergize with alterations in GATA-1 to immortalize hematopoietic progenitor cells. , 2009, Blood.

[40]  T. Rabbitts,et al.  The Ews-ERG Fusion Protein Can Initiate Neoplasia from Lineage-Committed Haematopoietic Cells , 2005, PLoS biology.

[41]  R. Lock,et al.  The nonobese diabetic/severe combined immunodeficient (NOD/SCID) mouse model of childhood acute lymphoblastic leukemia reveals intrinsic differences in biologic characteristics at diagnosis and relapse. , 2002, Blood.

[42]  S. Dhanasekaran,et al.  Distinct classes of chromosomal rearrangements create oncogenic ETS gene fusions in prostate cancer , 2007, Nature.

[43]  E. Lander,et al.  Gene expression signatures define novel oncogenic pathways in T cell acute lymphoblastic leukemia. , 2002, Cancer cell.

[44]  M. Caligiuri,et al.  Overexpression of the ETS-related gene, ERG, predicts a worse outcome in acute myeloid leukemia with normal karyotype: a Cancer and Leukemia Group B study. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[45]  Zhenhua Zhang,et al.  Expression of a CALM-AF10 fusion gene leads to Hoxa cluster overexpression and acute leukemia in transgenic mice. , 2007, Cancer research.

[46]  Zhaohui S. Qin,et al.  An integrated network of androgen receptor, polycomb, and TMPRSS2-ERG gene fusions in prostate cancer progression. , 2010, Cancer cell.

[47]  B. Blom,et al.  Development of human lymphoid cells. , 2006, Annual review of immunology.

[48]  S. Tsuzuki,et al.  Promotion and maintenance of leukemia by ERG. , 2011, Blood.

[49]  P. Kastner,et al.  Notch Activation Is an Early and Critical Event during T-Cell Leukemogenesis in Ikaros-Deficient Mice , 2006, Molecular and Cellular Biology.